Story perspectives

Supreme Court Restores Mifepristone Telehealth, Boosts Misoprostol Use

5/8/2026

Left

Supreme Court Restores Telehealth

Misoprostol-only abortion pills, cheaper and sold in retail pharmacies, are being promoted as a fallback as mifepristone access dwindles.
The Supreme Court granted a one-week stay, restoring telehealth prescribing and mailing of mifepristone after the Fifth Circuit blocked it.
Researchers say misoprostol-only protocols achieve 82-100 % effectiveness.
They could expand options for patients in strict-ban states, though clinicians lack counseling experience.

Right

Alito Restores

Supreme Court Justice Samuel Alito issued a temporary order blocking the Fifth Circuit decision.
The order restores nationwide mail and telehealth access to the abortion pill, effective until May 11 at 5 p.m.
The Department of Justice did not file a brief defending the FDA’s 2023 mail-distribution rule.
Students for Life president Kristan Hawkins called pill distributors “pill traffickers” and big-pharma beneficiaries.

Blindspot

Left coverage emphasized the promotion of misoprostol-only medication abortions, noting their lower cost, retail availability, and reported 82-100 % effectiveness as a fallback option.
Right coverage did not include the detail about misoprostol-only protocols or their potential role in expanding access where mifepristone is restricted.

History

Historical Context

After the 1992 Supreme Court ruling in Planned Parenthood v. Casey introduced the undue-burden test, states increasingly limited medication abortions, a trend amplified when Dobbs v. Jackson Women’s Health Organization overturned Roe in 2022. Justice Samuel Alito then authorized nationwide mail and telehealth delivery of mifepristone, reviving access for patients in states with strict bans.

1 of 4

Supreme Court Restores Telehealth

Misoprostol-only abortion pills, cheaper and sold in retail pharmacies, are being promoted as a fallback as mifepristone access dwindles.
The Supreme Court granted a one-week stay, restoring telehealth prescribing and mailing of mifepristone after the Fifth Circuit blocked it.
Researchers say misoprostol-only protocols achieve 82-100 % effectiveness.
They could expand options for patients in strict-ban states, though clinicians lack counseling experience.

1 / 4